NEVVI Medicare utilization intelligence

See the national market →

Jump to the result views

J1306 Injection, inclisiran, 1 mg HCPCS · Treatment
Classification Treatment › Injections and Infusions (nononcologic) (CMS RBCS)
First observed 2022
National scale 25.21M services · est. ▲ 110.6% YoY · 29,761 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 12.44M observed fee-for-service services
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window · National figures — the AZ market is below

See it in full: sestamibi, the nuclear heart-imaging tracer (A9500), in Arizona is open as a live example — every paid panel, on real data.

View the live example →
Disease-burden context Related condition
CDC BRFSS · age-adjusted · population survey

The condition this service manages

High cholesterol

34.2% of adults in AZ CDC BRFSS 2023, age-adjusted; 95% CI 32.7–35.7

27.3% lowest state  ·  AZ 34.2%  ·  39.5% highest state age-adjusted adult prevalence · CDC BRFSS 2023 · AZ position among all 52 states

Medicare FFS beneficiaries with the diagnosis (CMS CCW, 2023)

Hyperlipidemia · AZ · 66%

Share of Medicare fee-for-service beneficiaries with the CCW diagnosis flag; the same denominator as Nevvi's utilization counts. Context only — never combined with utilization.

The survey figure is what adults reported; the CCW figure is a diagnosis recorded on a Medicare claim, and the two are adjusted to different populations, so they are not expected to match. Source: CMS Chronic Conditions Warehouse, via the Mapping Medicare Disparities tool.

CDC BRFSS prevalence is survey data covering all-payer adults 18 and older; Nevvi utilization counts Medicare fee-for-service only, largely 65 and older. The two appear side by side as context — Nevvi never combines them into a score, rating, or ranking. See Methods.

Data year CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Filter results:
Market summary
Market Brief J1306
A shareable PDF report summarizing this market’s size, trends, and providers.
Preview this Brief →

This market's Overview — its estimated all-Medicare volume, national benchmarks, and what the field charges and is paid — is part of Explore.

See what Medicare pays

An Explore subscription, $249 a seat a year, opens the Overview on every code, group and clinician page, including what the market charges and is paid.

It comes with 25 credits a seat a year for Deep Dives, which open the rest.

Start with a 14-day trial. We’ll email you a one-time link to sign in.

View the live example →

Included in Explore. Part of a Deep Dive.

Browse Medicare billing by specialty →